COMMUNIQUÉS West-GlobeNewswire
-
Join Sharps Technology’s Exclusive Live Investor Webinar and Q&A Session on June 18
14/06/2024 - 19:40 -
Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)
14/06/2024 - 19:41 -
Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024
14/06/2024 - 22:01 -
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14/06/2024 - 22:05 -
ASLAN Pharmaceuticals Announces Plan to Implement ADS Ratio Change
14/06/2024 - 22:54 -
Umoja Biopharma Announces Publication in Blood Highlighting Successful Generation of In Vivo CAR T-cells in Non-Human Primate Modeling
13/06/2024 - 14:00 -
Opus Genetics Announces $1.7 Million in Project-based Funding from the Foundation Fighting Blindness to Support Two Preclinical Programs
13/06/2024 - 14:00 -
TOMI Environmental Solutions Supports Partners and Customers to Combat Global Avian Influenza (H5N1) Bird Flu Outbreak
13/06/2024 - 14:30 -
Intelligent Bio Solutions Implements Strategic Reorganization Plan to Support Global Growth Initiatives
13/06/2024 - 14:30 -
Replimune Announces $100 Million Private Placement Financing
13/06/2024 - 14:30 -
Sharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC Facility
13/06/2024 - 14:30 -
Aphaia Pharma Completes Enrollment in Arm 2 of Phase 2 Trial in Individuals with Obesity
13/06/2024 - 14:30 -
Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial
13/06/2024 - 14:30 -
NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting
13/06/2024 - 14:31 -
Aeroflow Health Celebrates New Growth Milestones & Reshares its Commitment to Employee Well-Being
13/06/2024 - 14:57 -
Scilex Holding Company to Present Poster on ELYXYB® (celecoxib oral solution) at the 66th Annual Scientific Meeting of the American Headache Society (AHS) to be Held in San Diego, CA on June 13-16, 2024
13/06/2024 - 15:00 -
VYNE Therapeutics Announces Dosing of First Participants in Phase 1a Trial of Novel BD2-Selective BET Inhibitor VYN202
13/06/2024 - 15:02 -
Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
13/06/2024 - 15:10 -
Positron Corporation Enters OEM Supply and Distribution Agreement for NeuSight PET-CT 64 Slice Scanner
13/06/2024 - 15:15
Pages